Correlation Between Mednax and Singular Genomics

Can any of the company-specific risk be diversified away by investing in both Mednax and Singular Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mednax and Singular Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mednax Inc and Singular Genomics Systems, you can compare the effects of market volatilities on Mednax and Singular Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mednax with a short position of Singular Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mednax and Singular Genomics.

Diversification Opportunities for Mednax and Singular Genomics

0.81

Correlation Coefficient

Mednax  Singular Genomics

Very poor diversification

The 3 months correlation between Mednax and Singular is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Mednax Inc and Singular Genomics Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Singular Genomics Systems and Mednax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mednax Inc are associated (or correlated) with Singular Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Singular Genomics Systems has no effect on the direction of Mednax i.e., Mednax and Singular Genomics go up and down completely randomly.

Pair Corralation between Mednax and Singular Genomics

Allowing for the 90-day total investment horizon Mednax is expected to generate 4.91 times less return on investment than Singular Genomics. But when comparing it to its historical volatility, Mednax Inc is 4.92 times less risky than Singular Genomics. It trades about 0.17 of its potential returns per unit of risk. Singular Genomics Systems is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  628.00  in Singular Genomics Systems on September 3, 2024 and sell it today you would earn a total of  1,543  from holding Singular Genomics Systems or generate 245.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Mednax Inc  vs.  Singular Genomics Systems

Mednax Inc

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Mednax Inc are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Mednax exhibited solid returns over the last few months and may actually be approaching a breakup point.

Singular Genomics Systems

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Singular Genomics Systems are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak forward indicators, Singular Genomics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mednax and Singular Genomics

The main advantage of trading using opposite Mednax and Singular Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mednax position performs unexpectedly, Singular Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Singular Genomics will offset losses from the drop in Singular Genomics' long position.

The idea behind Mednax Inc and Singular Genomics Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.